Comments on: FDA approves Spark Therapeutics’ Luxturna for retinal dystrophy /news/fda-approves-spark-therapeutics-luxturna-retinal-dystrophy/ The leading site for news and procurement in the pharmaceutical industry Thu, 21 Dec 2017 11:02:52 +0000 hourly 1 https://wordpress.org/?v=6.6.2